Therapeutic Drug Monitoring-guided High-dose Infliximab for Infantile-onset Inflammatory Bowel Disease: A Case Series-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapeutic Drug Monitoring-guided High-dose Infliximab for Infantile-onset Inflammatory Bowel Disease: A Case Series

Published:2020-07-06 Issue:4 Volume:71 Page:516-520
ISSN:0277-2116
Container-title:Journal of Pediatric Gastroenterology & Nutrition
language:en
Short-container-title:

Author:

Assa Amit,Dorfman Lev,Shouval Dror S.,Shamir Raanan,Cohen Shlomi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Pediatrics, Perinatology, and Child Health

Reference20 articles.

1. Trends in the epidemiology of inflammatory bowel disease among Jewish Israeli adolescents: a population-based study;Ghersin;Aliment Pharmacol Ther,2019

2. Incidence, outcomes, and health services burden of very early onset inflammatory bowel disease;Benchimol;Gastroenterology,2014

3. Very early onset IBD: how very different “on average”?;Turner;J Crohns Colitis,2017

4. Frequency of indeterminate colitis in children and adults with IBD - a metaanalysis;Prenzel;J Crohns Colitis,2009

5. Phenotypic and genotypic characterisation of inflammatory bowel disease presenting before the age of 2 years;Kammermeier;J Crohns Colitis,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Failure Rate of Anti-Tumor Necrosis Factor α Biologics in Very Early Onset Inflammatory Bowel Disease;Inflammatory Bowel Diseases;2024-01-11

2. The Benefit of Early and Frequent Antitumor Necrosis Factor-Alpha Trough Level Determination in Very Early-Onset Inflammatory Bowel Disease;ACG Case Reports Journal;2023-11

3. Dose escalation of adalimumab as a strategy to overcome anti-drug antibodies: A case report of infantile-onset inflammatory bowel disease;World Journal of Gastroenterology;2023-10-14

4. The Role of Therapeutic Drug Monitoring in Children;Gastroenterology Clinics of North America;2023-09

5. The Future of Advanced Therapies for Pediatric Crohn’s Disease;Pediatric Drugs;2023-08-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3